pipeline

a lot of scissors

Biotech

Takeda shoots down bispecifics bagged in Maverick buyout

The two bispecific terminations, coupled to the removal of a third asset, halved the number of cancer candidates in Takeda’s phase 1 and 2 pipeline.

Nick Paul Taylor May 8, 2025 8:30am

Illustration of the concept of layoff and downsizing of staff

Biomea cuts staff, drops leukemia asset in metabolic shift

May 5, 2025 6:59pm

reshuffle pipeline target reorganize shift change

Recursion streamlines pipeline following merger with Exscientia

May 5, 2025 11:00am

AstraZeneca culls neuroscience meds in Q1 clear-out

Apr 29, 2025 7:08am

Caribou antlers sitting on ground with mountains in background

Caribou cuts 32% of staff, further purges cell therapy pipeline

Apr 24, 2025 9:55pm

a lot of scissors

Evotec axes 30% of assets as cost-cutting push hits pipeline

Apr 17, 2025 9:45am